Print
Email
Print Edition StoriesMonday, July 13, 2009
Knee implant firm ConforMIS lands $50M investment
By Mass High Tech staff
MHT's Marc Songini: Technology to keep seniors healthy
MHT's Efrain Viscarolasaga: Tech companies may have to wait for stimulus funds
MHT's Marc Songini: RI plans launch of cord blood center
Burlington-based medical devices firm ConforMIS Inc. has raised $50 million from private equity and sovereign wealth funds in the U.S., Europe, Asia and the Middle East. Aeris Capital has invested the most funds for the company to date.
The company, which develops a customized bicompartmental knee resurfacing implant, intends to apply the financing to improve and grow its orthopedic implant technologies, ConforMIS Chairman and CEO Philipp Lang said in a press release. The technology is meant to provide an alternative to total knee replacements, which may remove healthy tissue in the process. The orthopedic implants designed by ConforMIS are built to match an individual’s CT or MRI scan.
Founded in 2004, ConforMIS has targeted the $20 billion global orthopedics market with its products, which are tied to more than 250 patents and patent applications. The company’s iDuo bicompartmental knee resurfacing system, iForma impant and iUni unicompartmental knee resurfacing system have all received CE Mark certification and U.S. Food and Drug Administration approval.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
